IRIS
FURNARI, MANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.235
AS - Asia 1.740
NA - Nord America 1.566
Continente sconosciuto - Info sul continente non disponibili 551
SA - Sud America 133
AF - Africa 31
OC - Oceania 30
Totale 17.286
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.925
US - Stati Uniti d'America 1.449
SG - Singapore 583
CN - Cina 418
VN - Vietnam 256
BD - Bangladesh 227
FR - Francia 118
BR - Brasile 66
CA - Canada 62
HK - Hong Kong 59
GB - Regno Unito 51
IN - India 41
DE - Germania 34
AR - Argentina 27
FI - Finlandia 26
IQ - Iraq 26
AU - Australia 24
JP - Giappone 24
MX - Messico 23
ID - Indonesia 18
ES - Italia 17
NL - Olanda 16
EC - Ecuador 14
SA - Arabia Saudita 13
TR - Turchia 12
PH - Filippine 10
CL - Cile 9
IR - Iran 8
JM - Giamaica 8
PK - Pakistan 8
TH - Thailandia 8
JO - Giordania 7
UA - Ucraina 7
CH - Svizzera 6
CO - Colombia 6
CR - Costa Rica 6
KE - Kenya 5
AT - Austria 4
EG - Egitto 4
ET - Etiopia 4
GT - Guatemala 4
IE - Irlanda 4
MA - Marocco 4
MY - Malesia 4
NI - Nicaragua 4
UZ - Uzbekistan 4
VE - Venezuela 4
DZ - Algeria 3
NZ - Nuova Zelanda 3
PE - Perù 3
PL - Polonia 3
PT - Portogallo 3
RU - Federazione Russa 3
TT - Trinidad e Tobago 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
FJ - Figi 2
GP - Guadalupe 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
IL - Israele 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MR - Mauritania 1
NP - Nepal 1
PF - Polinesia Francese 1
PY - Paraguay 1
SE - Svezia 1
SN - Senegal 1
TZ - Tanzania 1
UG - Uganda 1
Totale 16.737
Salva come PNG Salva come JPEG
Città #
Genova 7.131
Genoa 3.665
Vado Ligure 945
Rapallo 930
San Jose 297
Singapore 262
Ashburn 205
Lauterbourg 105
New York 84
Ho Chi Minh City 78
Beijing 76
Council Bluffs 62
Hanoi 62
Hong Kong 56
Santa Clara 39
Los Angeles 33
Milan 26
Frankfurt am Main 24
Orem 23
Tokyo 22
Rome 21
Bordighera 20
Helsinki 19
Buffalo 18
Boardman 16
Chicago 16
Naples 16
Phoenix 16
Toronto 14
Da Nang 13
Mumbai 13
Dallas 12
Mexico City 12
Montreal 12
Amsterdam 11
Athens 9
Florence 9
Haiphong 9
Jeddah 9
Philadelphia 9
São Paulo 9
Washington 9
Baghdad 8
Bologna 8
Boston 8
Brisbane 8
Erbil 8
London 8
Memphis 8
Wallsend 8
Amman 7
Atlanta 7
Cleveland 7
Columbus 7
Lappeenranta 7
Ocala 7
Seattle 7
Shanghai 7
Tianjin 7
Chennai 6
Houston 6
Hải Dương 6
Jersey City 6
San José 6
Santiago 6
Vancouver 6
Zurich 6
Brooklyn 5
Charlotte 5
City of London 5
Des Moines 5
Dublin 5
Guangzhou 5
Las Vegas 5
Melbourne 5
Nairobi 5
Newark 5
Padua 5
Poplar 5
Quito 5
San Francisco 5
Sydney 5
Addis Ababa 4
Bari 4
Brescia 4
Buenos Aires 4
Bắc Ninh 4
Cagliari 4
Calgary 4
Can Tho 4
Conway 4
Edmonton 4
Greensboro 4
Hamilton 4
Islamabad 4
Kingston 4
Kyiv 4
Lynnwood 4
Managua 4
Manila 4
Totale 14.739
Salva come PNG Salva come JPEG
Nome #
Side effects of long-term use of proton pump inhibitors: practical considerations 289
Proton pump inhibitors: use and misuse in the clinical setting 249
Incidental physiological sliding hiatal hernia: a single center comparison study between CT with water enema and CT colonography 232
The sensory system of the esophagus--what do we know? 229
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 223
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 215
Comparison of adenoma miss rate and adenoma detection rate between conventional colonoscopy and colonoscopy with second-generation distal attachment cuff: a multicenter, randomized, back-to-back trial 213
Advancements in the use of manometry and impedance testing for esophageal functional disorders 210
Measurement of oro-caecal transit time by magnetic resonance imaging. 209
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 206
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 204
A safety review of proton pump inhibitors to treat acid-related digestive diseases 202
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 200
Barrett's esophagus in 2016: From pathophysiology to treatment 199
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 192
Caution About Overinterpretation of Number of Reflux Episodes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease 192
Breath tests to assess alcoholic liver disease. 191
Gastric and masticatory performances in full-arch immediate loading rehabilitated patients 191
Comparison of computed tomography and magnetic resonance imaging in the discrimination of intraperitoneal and extraperitoneal rectal cancer: initial experience 188
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 186
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 185
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 182
Current treatment options for esophageal diseases. 181
A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients 181
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 180
Degree of colonic distension: intrapatient comparison between CT colonography and CT with water enema 176
Data on symptom association analysis in patients undergoing endoscopic therapy is useful to better define a successful therapeutic approach 171
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 169
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 168
Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: the perfect storm 165
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin 165
Harmonising proton pump inhibitors treatment in the specialist setting following the SIGE recommendations 161
The appropriate use of proton-pump inhibitors 161
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 160
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 160
Microscopic Esophagitis, Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave in Functional Heartburn: Useful Diagnostic Tools. 160
Optimal management of constipation associated with irritable bowel syndrome. 158
The natural history of gastro-esophageal reflux disease: A comprehensive review 155
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 153
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 147
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 146
Overweight is a risk factor for both erosive and non-erosive reflux disease. 146
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 145
Feasibility of the cut-and-push method for removing large caliber, soft, percutaneous endoscopic gastrostomy devices. 144
Course of oesophageal varices and performance of non-invasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease 143
Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery 142
It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients. 142
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 141
Basal cell hyperplasia and dilatation of intercellular spaces are the main histologic features associated to the endoscopic/impedance-pH diagnosis of GERD and its related mucosal integrity impairment 141
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 141
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 140
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 140
Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? 140
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 140
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients 139
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 138
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. 138
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 137
Gastrointestinal involvement in systemic sclerosis 137
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn 136
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. 135
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 131
Gastrointestinal motility disorder assessment in systemic sclerosis. 131
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? 131
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 130
Full-Dose Peginterferon Alfa-2a and Low-Dose Ribavirin Treatment of Genotypes 1 and 4 Chronic Hepatitis C Patients With End-Stage Renal Disease. 130
Hepatocellular carcinoma is the most frequent final diagnosis of focal liver lesions identified in a cross-sectional evaluation of patients with chronic liver disease in Saudi Arabia. 128
Applicability of Parameters for the Non-Invasive Diagnosis of Esophageal Varices Needing Treatment to Cured HCV Patients 127
Sniffing out causes of gastrointestinal disorders: A review of volatile metabolomic biomarkers 127
Esophageal testing: What we have so far 126
Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV 125
M01822 Diagnostic accuracy and Inter/Intra-observer Agreement between endoscopists with different expertise, before and after a short training, for the detection of gastric intestinal metaplasia by means of narrow band imaging with magnifying endoscopy 124
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool. 123
Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time 123
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease. 122
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered 122
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants. 122
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia 121
NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis 119
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 118
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data 118
Signet ring cell carcinoma of the stomach: correlation between endocytoscopy and histology 117
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 117
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 114
Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir 113
Esophageal motor disorders across ages: A retrospective multicentric analysis 112
Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. 111
Prevalence of active H. pylori infection and clarithromycin-contatining triple therapy efficacy in patients with dyspepsia-experience of a tertiary centre in North of Italy 111
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 111
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose 109
Treatment of early stage chronic hepatitis C virus infection 109
Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review 106
Esophageal baseline impedance values correlate with presence and severity of microscopic esophagitis in patients with gastro-esophaeal reflux disease 104
Hepatocellular Carcinoma Intermediate Stage Subclassification Systems: One, None, and One Hundred Thousand 104
Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. 102
Polyp and endoscopist-related factors influencing complication rates in difficult colonic polypectomies: results of a multicenter observational study 102
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 98
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 97
Letter: Treatment for small intestinal bacterial overgrowth - Where are we now? 96
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors. 96
Totale 15.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.419
article - articoli 55.960
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 459
Totale 112.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.209 82 31 69 121 35 128 44 304 80 141 38 136
2022/20231.122 123 107 28 85 189 152 6 92 212 6 111 11
2023/2024708 34 96 10 92 70 116 55 28 23 24 46 114
2024/20252.348 100 144 99 159 301 275 161 362 91 90 273 293
2025/20265.104 521 129 558 331 565 434 644 234 400 509 361 418
2026/2027447 447 0 0 0 0 0 0 0 0 0 0 0
Totale 17.286